Open Access

Rethinking and rechallenging RAASi therapy in patients with hyperkalaemia

Event: ESC CONGRESS 2020 - The Digital Experience
Topic: Treatment
Session type: Industry Q&A session
Organised by ChangeIME, supported by AstraZeneca in the form of an educational grant
Date: 30 August 2020
Time: 12:45 - 13:45

Congress Session

This content is currently on OPEN ACCESS

Sign in to view the resources

3 presentations in this session

Welcome and introduction.

Speaker: Doctor J. Butler (Jackson, US)
Speaker: Professor A. Voors (Groningen, NL)
Thumbnail

From clinical reasoning to clinical outcomes: are you making the right decisions following RAASi downtitration?

Speaker: Doctor P. McCullough (Texas, US)
Speaker: Doctor C. Gavina (Porto, PT)
Thumbnail

Sharing best practice in hyperkalaemia management.

Speaker: Professor A. Voors (Groningen, NL)
Speaker: Doctor J. Butler (Jackson, US)
Speaker: Doctor P. McCullough (Texas, US)
Speaker: Doctor C. Gavina (Porto, PT)
Thumbnail

8 speakers from this session

Doctor Javed Butler

The University of Mississippi Medical Center, Jackson (United States of America)
71 presentations
3 followers

Professor Adriaan Voors

University Medical Centre Groningen, Groningen (Netherlands (The))
52 presentations
0 follower

Doctor Peter McCullough

, Texas (United States of America)
0 follower

Doctor Cristina Gavina

Faculty of Medicine University of Porto, Porto (Portugal)
2 presentations
0 follower

Professor Adriaan Voors

University Medical Centre Groningen, Groningen (Netherlands (The))
52 presentations
0 follower

Doctor Javed Butler

The University of Mississippi Medical Center, Jackson (United States of America)
71 presentations
3 followers

Doctor Peter McCullough

, Texas (United States of America)
0 follower

Doctor Cristina Gavina

Faculty of Medicine University of Porto, Porto (Portugal)
2 presentations
0 follower

This platform is supported by

logo Novo Nordisk